Biomanufacturing and life sciences
Where science meets
scale
Canada is a global hub for health innovation, with a vibrant ecosystem spanning pharmaceuticals to medtech and more than 3,800 life sciences companies driving biomanufacturing and investment.
Established industry leaders like AstraZeneca and Siemens are expanding their R&D and manufacturing operations in Canada. With world-class scientific expertise and a stable regulatory environment, Canada continues to be a top choice for global companies with bold ambitions.
At the heart of Canada’s success is its deep talent pool. With thousands of scientists, engineers and technicians trained each year, you’ll have access to the expertise your company needs to scale quickly and compete globally.
Find out how Canada can help you shape the future of healthcare.
Canadian leadership in biomanufacturing and life sciences
Over $3.2 billion
Pharmaceuticals
The Canadian pharmaceutical market is the sixth largest in the world. Its efficient regulatory environment provides a welcoming climate for pharmaceutical operations.
Large life sciences centres in major Canadian cities connect research, talent and infrastructure. With this strong foundation, it’s easier to accelerate product development and get to market.
Vaccine manufacturing
Canada is a powerhouse for vaccine research and manufacturing. Thanks to strategic investments in mRNA, monoclonal antibodies and AI-driven solutions, it offers a healthy biomanufacturing ecosystem to support investment.
Join major players like Moderna, Pfizer and Sanofi, who are investing in Canada’s vaccine future – expanding their footprints and accelerating production.
Clinical trials
Canada ranks #1 in clinical trial productivity among G7 nations. When you invest in Canada, you get access to internationally recognized clinical trial networks and public research infrastructure backed by government.
Health Canada regulates clinical trials, making trials faster and more flexible. The public healthcare system ensures access to a diverse patient base and consistent trial execution.
Medtech
Canada’s medtech sector is home to over 2,000 companies developing technologies that give patients access to more effective disease diagnosis, treatment and monitoring. The rapidly growing medical technology industry spans the entire continuum of care, from diagnostics to advanced treatments.
With a strong talent pipeline and robust regulatory framework, Canada is home to the fourth largest number of active biotechnology firms in the OECD, the country offers deep expertise in precision healthcare and patient-focused technologies.
Why choose Canada
Robust industry regulations
Strong intellectual property protections
Globally recognized universities and research institutions
Lowest costs in the G7 for biotech, clinical trials and product testing
Explore Canada’s leading industries
Let’s work together
At Invest in Canada, we are dedicated to your company’s success.
Our team is your trusted guide to investing in Canada. We get to know your business, offer insights and information and connect you with the right people and places to support your decision.